Loading...
Gemina Laboratories Ltd.
GLAB.CN•CNQ
HealthcareBiotechnology
CA$1.02
CA$0.12(10.91%)
Gemina Laboratories Ltd. (GLAB.CN) Stock Overview
Explore Gemina Laboratories Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for GLAB.CNStats details for GLAB.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for GLAB.CNAnalyst Recommendations details for GLAB.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.
CEO
Mr. Brian Firth
Employees
6
Headquarters
3800 Westbrook Mall, Burnaby, BC
Founded
2021